Inhibrx Stock Buy Hold or Sell Recommendation

INBX -  USA Stock  

USD 39.82  1.36  3.54%

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Inhibrx is 'Strong Hold'. Macroaxis provides Inhibrx buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Inhibrx positions. The advice algorithm takes into account all of Inhibrx's available fundamental, technical, and predictive indicators you will find on this site.

Inhibrx Advice 

The advice is provided from Inhibrx's buy-and-hold perspective. Please see Inhibrx Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Inhibrx and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Inhibrx.

Execute Inhibrx Buy or Sell Advice

The Inhibrx recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Inhibrx. Macroaxis does not own or have any residual interests in Inhibrx or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Inhibrx's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell InhibrxBuy Inhibrx
Strong Hold


Not too volatileDetails

Hype Condition

Over hypedDetails

Current Valuation


Odds of Distress


Economic Sensitivity

Barely shadows the marketDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)


Financial Leverage


Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Inhibrx has a Risk Adjusted Performance of 0.0979, Jensen Alpha of 0.5486, Total Risk Alpha of 0.3029, Sortino Ratio of 0.1453 and Treynor Ratio of 3.31
Inhibrx investment recommendation module can be used to check and cross-verify current trade recommendations provided by analysts evaluating the entity's potential to grow using all of fundamental, technical, data market data available at the time. To make sure Inhibrx is not overpriced, please check out all Inhibrx fundamentals, including its price to sales, as well as the relationship between the cash and equivalents and cash flow from operations . Given that Inhibrx has a shares owned by insiders of 40.06 %, we strongly advise you to confirm Inhibrx market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Inhibrx Trading Alerts and Improvement Suggestions

Inhibrx appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 12.9 M. Net Loss for the year was (75.32 M) with loss before overhead, payroll, taxes, and interest of (60.61 M).
Inhibrx currently holds about 107.99 M in cash with (62.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.86.
Inhibrx has a poor financial position based on the latest SEC disclosures
Roughly 40.0% of the company shares are held by company insiders
Latest headline from Inhibrx falls 0.73 percent on Moderate Volume October 15 -

Inhibrx current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Inhibrx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Inhibrx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price40.50
Target Median Price41.00
Target High Price45.00
Recommendation Mean1.70
Number Of Analyst Opinions4
Target Low Price35.00
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Inhibrx Returns Distribution Density

The distribution of Inhibrx's historical returns is an attempt to chart the future uncertainty of Inhibrx's future price movements. The chart of the probability distribution of Inhibrx stock daily returns describes the distribution of returns around its average expected value. We use Inhibrx price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Inhibrx returns is essential to provide solid investment advice for Inhibrx stock.
Mean Return0.57Value At Risk-5.62
Potential Upside5.78Standard Deviation4.51
 Return Density 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Inhibrx historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Inhibrx Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Inhibrx or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Inhibrx stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Inhibrx stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW0.17
Overall volatility
Information ratio 0.11

Inhibrx Volatility Alert

Inhibrx shows above-average downside volatility for the selected time horizon. We advise investors to inspect Inhibrx further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Inhibrx future alpha. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Inhibrx's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Inhibrx's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Inhibrx Fundamentals Vs Peers

Comparing Inhibrx's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Inhibrx's direct or indirect competition across all of the common fundamentals between Inhibrx and the related equities. This way, we can detect undervalued stocks with similar characteristics as Inhibrx or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Inhibrx's fundamental indicators could also be used in its relative valuation, which is a method of valuing Inhibrx by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Inhibrx to competition
FundamentalsInhibrxPeer Average
Return On Equity(567.79) %(0.31) %
Return On Asset(58.63) %(0.14) %
Operating Margin(529.95) %(5.51) %
Current Valuation877.22 M16.62 B
Shares Outstanding37.81 M571.82 M
Shares Owned by Insiders40.06 %10.09 %
Shares Owned by Institutions43.12 %39.21 %
Number of Shares Shorted779.1 K4.71 M
Price to Sales116.35 X11.42 X
Revenue12.9 M9.43 B
Gross Profit(60.61 M)27.38 B
EBITDA(67.34 M)3.9 B
Net Income(75.32 M)570.98 M
Cash and Equivalents107.99 M2.7 B
Cash per Share2.86 X5.01 X
Total Debt37.3 M5.32 B
Debt to Equity0.61 %48.70 %
Current Ratio4.07 X2.16 X
Cash Flow from Operations(62.23 M)971.22 M
Short Ratio5.77 X4.00 X
Number of Employees8418.84 K
Market Capitalization1.5 B19.03 B
Z Score24.08.72
   Acquisition by Kayyem Jon Faiz of 15000 shares of Inhibrx subject to Rule 16b-3 [view details]

About Inhibrx Buy or Sell Advice

When is the right time to buy or sell Inhibrx? Buying financial instruments such as Inhibrx Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Inhibrx investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2010 2019 2020 2021 (projected)
Current Assets5.66 M15.56 M132.17 M142.61 M
Total Assets9.98 M26.49 M143.74 M155.09 M

Use Investing Ideas to Build Portfolios

In addition to having Inhibrx in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Retail Thematic Idea Now

Retail Theme
Fama and French focuses on testing asset pricing under different economic assumptions. Retail theme has 61 constituents.
View All  Next Launch Retail
Please see Inhibrx Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Inhibrx information on this page should be used as a complementary analysis to other Inhibrx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Inhibrx Stock analysis

When running Inhibrx price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Valuation
Check real value of public entities based on technical and fundamental data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
The market value of Inhibrx is measured differently than its book value, which is the value of Inhibrx that is recorded on the company's balance sheet. Investors also form their own opinion of Inhibrx's value that differs from its market value or its book value, called intrinsic value, which is Inhibrx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inhibrx's market value can be influenced by many factors that don't directly affect Inhibrx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inhibrx's value and its price as these two are different measures arrived at by different means. Investors typically determine Inhibrx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inhibrx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.